|
LEPROTL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23180363079223E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.29256671611256E-13 |
| Normal-vs-Stage2 |
7.090300E-02 |
| Normal-vs-Stage3 |
1.03930000050489E-07 |
| Normal-vs-Stage4 |
4.77770000006927E-07 |
| Stage1-vs-Stage2 |
1.988290E-04 |
| Stage1-vs-Stage3 |
9.614100E-02 |
| Stage1-vs-Stage4 |
8.542000E-01 |
| Stage2-vs-Stage3 |
1.362400E-02 |
| Stage2-vs-Stage4 |
4.658500E-03 |
| Stage3-vs-Stage4 |
3.108400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.54549722914044E-11 |
| Normal-vs-AfricanAmerican |
3.96930000000628E-05 |
| Normal-vs-Asian |
3.82470000115376E-08 |
| Caucasian-vs-AfricanAmerican |
2.372600E-01 |
| Caucasian-vs-Asian |
5.085000E-01 |
| AfricanAmerican-vs-Asian |
5.382200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.4325000003731E-08 |
| Normal-vs-Female |
1.66400226930818E-11 |
| Male-vs-Female |
5.118200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.8286483438601E-12 |
| Normal-vs-Age(41-60Yrs) |
4.38580000095001E-08 |
| Normal-vs-Age(61-80Yrs) |
2.0893999999938E-05 |
| Normal-vs-Age(81-100Yrs) |
2.339300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.584600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.217300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.027600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.852400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.118200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.760800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.278200E-01 |
| Classical-VS-Follicular |
5.9992011358645E-11 |
| Classical-VS-Other |
9.884400E-02 |
| Classical-VS-Normal |
1.0769163338864E-14 |
| Tall-VS-Follicular |
1.219400E-04 |
| Tall-VS-Other |
7.142100E-02 |
| Tall-VS-Normal |
1.17439999947067E-08 |
| Follicular-VS-Other |
5.971000E-01 |
| Follicular-VS-Normal |
1.133000E-01 |
| Other-VS-Normal |
1.241800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.40120000011879E-07 |
| Normal-vs-N1 |
4.22190000004541E-06 |
| N0-vs-N1 |
1.749760E-01 |
|
|
